Back to Top


February 23, 2015; Posted by: WeBleed staff

Baxter releases location of spinoff, Baxalta, in Bannockburn, Illinois.

Baxter International announced today that its new pharmaceutical spinoff, Baxalta, will be located not far from Baxter’s headquarters in Bannockburn, Illinois and completed later on this year.

“Selecting Baxalta’s global headquarters is a key milestone on our journey to becoming a leading, independent biopharmaceutical company, and reaffirms our commitment to northern Illinois and our strong employee base here,” said Ludwig Hantson, president of Baxter BioScience, who will be chief executive officer of Baxalta, in a statement from Chicago Tribune.¬†

Baxalta will continue to focus on rare conditions and chronic diseases like hemophilia and gene therapy research.

Photo Credit РBaxter International – your source for bleeding news!

Comment Here

Your email address will not be published.


Translate »